Research Initiative

Collaboration Title	Collaboration Type	HHS Participating Agencies	NIH Participating Institutes/ Centers/ Office of the Director	Year Collaboration Originated
FDA Collaboration - Psilocybin Research	Research Initiative	FDA	CC	2020
Federal Interagency Forum for Child and Family Statistics	Research Initiative	ACF, AHRQ, CDC, HRSA, OS, SAMHSA	NICHD, NIMH	2010
Federal Interagency Task Force on the Arts and Human Development	Research Initiative	ACF, ACL, SAMHSA	NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR	2011
FNIH Advanced Medicines Partnership on Gene Therapy	Research Initiative	FDA	NCATS	2019
FNIH Biomarkers Consortium	Research Initiative	CMS, FDA	NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NINDS	2006

Funding levels reported in the Fiscal Year 2020 Intra-Agency Collaborations Reporting System (CRS) may not be consistent with funding levels reported under the Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) at the NIH Office of Budget Website at http://report.nih.gov/categorical_spending.aspx. The current process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. RCDC use of data mining improves consistency and eliminates the wide variability in defining the research categories reported. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.